Appendix IV Research Work Group Report
Prepared by the Research Work Group of the
Subcommittee on Risk Management Committee
Coordinate Environmental Health and Related Programs
April 3, 1992
Research Work Group Leader:
Stanford Hamburger, D.D.S., M.P.H. Food and Drug Administration
Research Work Group Members:
Thomas Callahan, Ph.D. - Food and Drug Administration
Stephen Corbin, D.D.S., M.P.H. Centers for Disease Control and Prevention
Jeffery Gift, Ph.D. - Environmental Protection Agency
Peggy Hamilton - Food and Drug Administration
Annie Jarabek - Environmental Protection Agency
Mark McClanahan, Ph.D. - Centers for Disease Control and Prevention
Kevin Tonat, M.P.H. - National Institutes of Health
INTRODUCTION
A major concern facing the public health and professional communities, as well as the public, is the potential for adverse health effects associated with the use of dental amalgam/mercury restorative materials. This concern has led the Public Health Service (PHS) to develop comprehensive scientific reviews of the risks and benefits of dental amalgam use. Pursuant to these reviews, the Committee to Coordinate Environmental and Health Related Programs (CCEHRP), through its Risk Management Subcommittee (RMS), formed three work groups to develop reports addressing professional and public education, regulation, and research recommendations related to the use of dental amalgam and human health. This report by the Research Work Group (RWG) is in response to five charges that were provided by the RMS as follows:
The RWG conducted extensive discussions of the charges which resulted in general agreement that the philosophical approach would be based on the public health aspect(s) of scientific research with an emphasis on what research would best address two important public health policy questions:
"Should dental amalgam continue to be recommended for use?" and, if not,
"Should existing dental amalgam restorations be removed and replaced with another material?"
These policy questions cannot be addressed with confidence until we obtain answers to several fundamental questions relative to potential adverse effects of mercury on human health that include:
Similar to the issues of lead neurotoxicity, mechanistic research on mercury toxicity and the dynamics of its release from dental amalgams is crucial given the limitations of epidemiologic evidence. Issues such as measuring doseresponse at very low levels, bioavailability, relative persistence of the effects of early exposures, and the identification of critical periods of sensitivity will not be identified by epidemiologic studies alone. Such studies are generally imprecise in terms of dose and they are frequently confounded by the multitude of variables present in human populations.
It is important to recognize that the changing manner of dental practice has a continuing impact on how dental amalgam is used and how its "risks" and "benefits" are assessed. Average caries scores, especially for children and adolescents, continue to diminish. This reduction is largely attributable to the widespread use of fluorides, especially community water fluoridation. Dental amalgam remains the most commonly used dental restorative material, with nearly 50 percent of dental restorative procedures still involving the use of dental amalgams. However, its use is declining as caries scores decline and alternative materials are substituted. Effective preventive methods (e.g. sealants) and the utilization of new and improved materials and techniques now permit a wider spectrum of clinical choices.
Charge 1: To evaluate research recommendations presented
in the risks and benefits reports.
Background
The members of the RWG reviewed and accepted the amalgam benefits and risks reports as expert reviews and used them as a starting point for identifying and characterizing research needs. Numerous research recommendations were included in the reports, some general and some specific.
Each RWG member was asked initially to review and evaluate these recommendations. Additionally, RWG members were asked to identify questions or items suggested in the text of those reports that were not specifically addressed in the recommendations sections. These, in addition to the NIH Technology Assessment Conference document entitled Dental Restorative Materials and the recent FDA Dental Panel Report, comprise a rather complete inventory on amalgam safety and benefit issues. Additionally, research recommendations from the WHO International Programme on Chemical Safety (IPSC) Environmental Health Criteria 118 Inorganic Mercury were also considered.
Findings
Based on recent literature reviews, we conclude that several critical parameters relating to mercury toxicity and human health are unresolved: the specific health effects of low level mercury exposure, if any; the relevant absorption, distribution, metabolism, and elimination; putative biological markers of exposure and effect; the medical consequences; and, the significance of blood, urine, or tissue levels of mercury. Observations from the source reports cited that support this conclusion include the following:
Charge 2: To develop rating criteria for identifying
and prioritizing research initiatives.
Background
The RWG discussed extensively the merits of developing a numerically based ranking system for purposes of establishing research priorities relative to dental amalgam. It was recognized that even if such a system were to be developed, its validity, objectivity, and usefulness would remain to be determined. Similar issue-specific systems or a generic system have not yet been developed for ranking research needs and opportunities in other CCEHRP areas of concern to the Work Group's knowledge. Additionally, it was apparent, after review of the risks and benefits reports, that there are so many areas meriting additional scientific research, developing a special ranking instrument at this time may be superfluous.
As an alternative approach, members of the RWG independently reviewed the risks and benefits reports, along with the abstracts from the NIH Technology Assessment Conference, and the WHO IPSC report and developed lists of research questions and needs. The RWG then employed an iterative delphi type process to develop a list of the most fundamental and important areas for research that could practically be pursued in the immediate future. These are areas felt to be most critical to sound public health decision-making. Notwithstanding this approach, a more extensive list of issues meriting additional research attention, reflecting an integration of individual RWG member efforts, are identified in Attachment 1 of this report.
Findings
Two major areas of research questions were identifiedquestions that were principally methodological or those that were substantive relative to the effects and mechanisms of mercury actions on human health, whether from dental amalgam or other sources.
Priority Areas For Research
Additional methodological concerns include:
Recommendations
Very specific research questions/ studies/designs should be reviewed by experts in the topical subject areas. An extensive list of currently funded research projects is appended (Attachment 2) that reflects RWG consensus as bearing on many of the scientific questions at issue.
Charge 3: To address the viability of developing an intramural
tracking mechanism to insure that meritorious research projects
are properly considered and funded within the Public Health Service.
Background
The RWG adopted the position that existing intramural research projects, whether conducted by PHS researchers or through extramural grants, are meritorious by virtue of the review processes they must undergo before approval or award.
A first approximation of research projects relevant to dental toxicity, mercury amalgam, and alternative dental restorative materials conducted throughout the PHS was obtained by conducting several searches of the PHS CRISP database (Attachment 2).
In order to ensure that duplicative efforts would be minimized, the RWG consulted with the CCEHRP Subcommittee on Research Needs on its concurrent efforts to develop a research tracking system for specific areas of interest to CCEHRP.
Findings
An Intramural tracking mechanism to identify and monitor research projects funded within the PHS is a viable undertaking. Alternative mechanisms of obtaining relevant information, such as CRISP (Attachment 3), are available but do not currently address the full requirement of this charge.
Recommendations
The system should be clearly distinguished from a system to track recipients of dental amalgam or a postmarket surveillance system. This system would essentially be a registry of research projects supported and/or sponsored by PHS agencies. The administration of a system is of prime importance. Since it is to encompass all of the PHS and is to be a tool for the Assistant Secretary for Health (ASH), it should be administered by that office and could be delegated by the ASH to a lead agency or committee. In order to be comprehensive, the system should include information from sister agencies (i.e., EPA, DOD) and the private sector.
A proposed intramural tracking system should incorporate, at a minimum the following information for each project:
All agencies would need access to the system in order to be able to identify areas of current and needed research and to decide how they would like to prioritize or solicit grant applications or project requests. Cooperation from participating agencies will be vital in order to establish a system that will be a viable tool for agency manages.
Charge 4: To advise whether the use of dental sealants and other preventive restoration can further reduce the incidence of caries and thus, the need for amalgam restorations.
Background
Dental amalgam restorations have long been the mainstay of dental restorative practice. In fact, in previous decades when dental caries scores were much higher than today, it was not uncommon for many individuals to have dental amalgam restorations in virtually all their posterior teeth. Declining caries scores are a result of widespread preventive efforts, largely fluorides in drinking water and dental products. Dental sealants, which have been available for two decades, have only recently come into increasing prominence. In 1989, approximately 13% of 8-year-olds and 17 percent of 14-year-olds had received dental sealants. The PHS, through the Healthy People 2000 initiative, has established the goal that by the Year 2000, 50 percent of children will have received dental sealants.
Sealants prevent caries by acting as barriers. Sealants fill surface pits and fissures that are prone to the development of caries. Caries protection may be determined by the sealants' ability to remain adhered to the tooth. As long as the sealant remains intact, caries will not develop beneath it. However, even where sealants have been partially lost, some protection may be gained from residual sealant occluding the depth of the pit or fissure. Still, the longevity of a sealant on a tooth is a prime determinant of success. Sealants are underused in both private and public health care delivery systems. Expanding the use of sealants would reduce the occurrence of dental caries in the population, and particularly among children.
Findings
The report on the benefits of dental amalgam has concluded, based on extensive scientific evidence, that dental sealants are extremely effective in preventing decay in the pits and fissures that are common to the chewing surfaces of the posterior teeth This is important since fluoride is only partially effective in preventing caries on these surfaces.
Historically, the near universal choice for dental restorative material in the majority of restoration situations for posterior teeth has been amalgam. However, newer materials and techniques, most notably the preventive resin restoration, and improved composite materials are modifying the "standard" choice in defined situations. With an ever strengthening commitment to preserving as much sound tooth structure as possible, dentists are increasingly relying on non-amalgam restorative materials where the physical stress requirements of a particular restorative situation permit. Plastic filling materials can be used by themselves or in combination with sealants where the extent of caries is conservative. Acid etching techniques that enhance retention of the restorations are substituted for the creation of undercut areas in the tooth preparation to prevent dislodgement. This results in the removal of less sound tooth structure.
Another alternative to dental amalgam in defined restorative situations are the glass ionomers. Since these materials do not resist stress well, they cannot be used in areas of heavy occlusal contact. They offer an added advantage of containing fluoride that can leach out and provide a supplemental caries preventive effect. Glass ionomers, like resins, are tooth colored and thus superior to dental amalgam from an esthetics standpoint.
Still, it must be remembered that the majority of posterior restorative situations do not permit the use of plastic fillings or glass ionomers. This is particularly true of replacement restorations that may need to be large or that restore areas of heavy occlusal contact. With caries scores declining in children and with individual carious lesions being generally less extensive than in the past, there is likely to be increasing substitution of these alternative materials for dental amalgam in the future.
Recommendations
Expanding the use of dental sealants and alternative materials to dental amalgam, where appropriate, should be promoted to the public and the dental profession.
Charge 5: In consultation with the Regulation Work Group, examine the relevance and utility of adverse effects information—collected from FDA's Medical Device Reporting and Problem Reporting Programs—for ongoing and future research initiatives, and explore means for exporting such data to government and private researchers
.Background
Historically, little use has been made of the reporting system for dentally-related concerns. Thus, it has been of little utility for research purposes.
Findings
The relevance and utility of adverse effects information collected from the Food and Drug Administrations's MDRs and PRP for ongoing and future research is limited. A plethora of reports have been filed with chief complaints that were claimed to be resolved with the removal of amalgam/mercury restorations.
These reports, on relatively few subjects, may reflect a "selection bias." Approximately 550 reports have been entered into the system. The patients were self-selected and not representative of the general population. Representativeness is a basic requirement underlying statistical analysis. Preliminary frequencies relative to age, geographical distribution, and symptoms can only be considered as counts. The lack of population based data for comparisons severely limits any useful determinations. Reporting on these systems is not intended to provide precise quantifications of actual population-based risks. The MDRs and PRP are most useful for preliminary assessments of whether more formal surveillance or specialized studies are merited.
Recommendations
Only aggregate data are available from the MDRs and PRP reporting systems. Because of the limitations cited above, their value to researchers or others is severely restricted. Therefore, efforts to make the data more widely available are not likely to be useful.
SUMMARY
Based on comprehensive scientific reviews of the risks and benefits of dental amalgam, the RWG has identified an extensive list of research opportunities and needs relative to the safety and utility of dental amalgam and alternative dental restorative materials. Additionally, a smaller list of high priority research areas has been drawn from the comprehensive list, based on the potential to provide a sound basis for public health decision making about the continued use of dental amalgam.
There are enough areas of fundamental research merited, both in terms of low level mercury effects on human health in general and mercury vapor from dental amalgam in particular, that definitive answers will require research efforts over a period of many years. The available research evidence is not specific enough or strong enough to make sound pronouncements about human health risks from dental amalgam. Given the potential that end effects from low levy mercury exposure may well be subtle and non-specific and that the relative importance of various forms and sources of mercury are not clearly established, much work remains.
At the same time, it is encouraging that a wide range of research is already being conducted that should help to answer questions of potential mercury toxicity, as well as the safety and utility of alternative dental restorative materiels. A tracking system has been proposed that will permit the ongoing assessment of research efforts that bear on these questions. Agencies that carry out or sponsor research related to these questions could utilize the tracking system to assess how their resources could best be applied to addressing the most important scientific questions for making sound public policy decisions.
Unlike many areas of potential health risk where extensive research remains to be conducted, a marked decline in exposure to the potential risk agent is already taking place as a result of declining caries rates, improved dental materials and treatment methods, and preference of the public for tooth colored rather than metal colored restorations.
Attachment 1
Dental Amalgam Research Questions/Work Statements
(non-prioritized) Identified from the "Risks" and "Benefits"Reports1
1
Major dental amalgam research gaps were identified in the response to Charge 1 and priority areas and methodological issues were listed in the response to Charge 2.Attachment 2
Draft Selection of PHS Supported Research Potentially Related
to Dental Amalgam Risks and Benefits
Project ID |
Project Title |
Award |
Fiscal |
5 P01 AG05119-07 |
Biochemical, morphological, and trace element studies—Alzheimer's disease SUB TITLE Trace elements studies in Alzheimer's disease |
$143,855 |
FY91 |
1 R01 AG10664-01 |
Alzheimer's disease, dental amalgams and mercury (human) |
$165,615 |
FY91 |
1 P60 AR40770-OIA1 |
Multipurpose arthritis and musculoskeletal diseases center |
$100,902 |
FY91 |
2 R01 DE02936-23 |
Relationship of microstructure to behavior of amalgam (human) |
$158,172 |
FY91 |
2 R55 DE06112-09A1 |
Filled sealant as a conservative restorative material |
$100,000 |
FY91 |
5 R37 DE06374-10 |
Semi-and nonprecious metal-porcelain systems |
$226,593 |
FY91 |
5 R01 DE0653948 |
Breakdown of amalgam margins—A microstructural study (human) |
$175,486 |
FY90 |
5 R01 DE06563-08 |
Microstructure vs. deterioration of amalgam restorations |
$70,179 |
FY91 |
5 R01 DE06672-09 |
Optimization of restoration design |
$168,803 |
FY91 |
5 R01 DE07644-06 |
Evaluation of mercury release from dental amalgam |
$139,889 |
FY91 |
5 R01 DE07754-06 |
Dissolution of mercury from dental amalgams |
$146,685 |
FY91 |
5 R01 DE07806-06 |
Thermally induced changes in dental porcelain expansion |
$117,088 |
FY91 |
5 R01 DE08222-02 |
Optimizing corrosion testing of dental alloys (humans) |
$152,693 |
FY91 |
5 R01 DE08651-03 |
Evaluation of protection hypothesis for composite wear (humans) |
$188,571 |
FY91 |
5 R01 DE08587-03 |
Mercury and leukocyte function (human) |
$173,066 |
FY91 |
5 R44 DE08905-03 |
Low-noble metal content duplex dental alloys |
$219,945 |
FY91 |
1 R15 DE08984-01 |
Expanding composite matrixes for dental restoration |
$51,935 |
FY89 |
1 R01 DEO9292-01A1 |
In vivo/in vitro wear performance of posterior composite (human) |
$184,568 |
FY91 |
5 P50 DE09307-03 |
Specialized materials science research center SUB TITLE Controlled release of diagnostic and therapeutic agents |
$178,913 |
FY91 |
1 P01 DE09696-01 |
Improved polymeric restorative through molecular design |
$131,650 |
FY91 |
3P30ES00159-24S1 |
Environmental health sciences center |
$146,942 |
FY91 |
5 K04 ES00163-04 |
Mechanism of mercury toxicity and carcinogenicity cells |
$64,730 |
FY91 |
5 K04 ES00178-04 |
Neurotoxic mechanism of methylmercury poisoning |
$70,200 |
FY91 |
5 P30 ES01247-18 |
Environmental Health Sciences Center |
$206,504 |
FY91 |
5 P30 ES01247-17 |
Trace contaminants as environmental heath hazards to man |
$64,304 |
FY91 |
5 R01 ES02453-12 |
Renal reabsorption of glutamate (rabbits, rats) |
$120,188 |
FY91 |
5 R01 ES02573-09 |
Mercury neurotoxicitive role of lipoperoxidation injury |
$104,880 |
FY90 |
5 R01 ES02654-10 |
Genetics of thionein and tolerance to metals (Drosophila) |
$161,986 |
FY91 |
5 R01 ES02928-10 |
Effects of methylmercury on fetal brain (mice, human) |
$246,859 |
FY90 |
5 R01 ES03179-09 |
Immunotoxicology of heavy metals (mice, human) |
$187,387 |
FY91 |
2 R01 ES03230-04A2 |
Immune effects of metals—Mercury-induced autoimmune disease (rats) |
$139,039 |
FY91 |
5 R01 ES03299-08 |
Neurotoxic mechanism of acute methylmercury poisoning |
$116,905 |
FY9I |
5 R01 ES03543-05 |
Epigenetic mechanisms of toxicity of environmental metals |
$126,950 |
FY91 |
5 R01 ES03628-06 |
Trace metal alteration of renal porphyrin metabolism (rats) |
$108,883 |
FY91 |
5 R01 ES03745-05 |
Primate developmental effects of methyl mercury (Macaca, rats) (Repro/Devel) |
$281,572 |
FY91 |
5 R01 ES03928-06 |
Neurotoxic mechanisms in primary CNS cell cultures (mice) |
$121,602 |
FY91 |
5 R29 ES04722-04 |
Methyl mercury & neuronal protein phosphotylation (rats) |
$87,815 |
FY91 |
5 R01 ES04803-04 |
Effects of xenobiotics on renal membrane transport (rats) |
$116,229 |
FY91 |
5 P42 ES04895-03 |
Detect and predict human exposure to toxic chemicals |
$201,068 |
FY91 |
5 P42 ES04895-03 |
Detect and predict human exposure to toxic chemicals SUB TlTLE Hair follicle keratinocytes as indicators of toxic and carcinogenic |
$201,068 |
FY9I |
5 P42 ES04895-03 |
Detect and predict human exposure to toxic chemicals SUB TITLE Bioconcentration and bioaccumulation of chemicals in striped bass |
$201,068 |
FY91 |
5 P42 ES04895-03 |
Detect and predict human exposure to toxic chemicals SUB TITLE Core—Exposure, analytical chemistry and biostatistics |
$201,068 |
FY91 |
5 R01 ES04976-03 |
Mechanisms of MeHg neurotoxicity during development (mice) |
$144,609 |
FY91 |
5 R01 ES05011-03 |
Long-term organic/inorganic mercury neurotoxicity (macaque) |
$274,488 |
FY91 |
5 R29 ES05157-04 |
Mercury nephrotoxicity after a reduction of renal mass (mass) |
$85,656 |
FY91 |
1 P01 ES05197-OIA1 |
Health hazards of methylmerury |
$724,603 |
FY91 |
1 P01 ES05197-OIA1 |
Health hazards of methylmercury SUB TITLE Child development following prenatal methyl mercury exposure via fish diet |
$120,767 |
FY91 |
1 P01 ES05197-OIA1 |
Health hazards of methylmercury |
$120,767 |
FY91 |
1 P01 ES05197-OIA1 |
Health hazards of methylmercury SUB TITLE Core—Morphology and histochemistry (human tissue) |
$120,767 |
FY91 |
1 PO1 ES05197-OLA1 SUB:9003 |
Health hazard of methylmetcury SUB TITLE Core—Analytical |
$120,767 |
FY91 |
5 RO1 ES05252-02 |
Effect of Hg and Cd on B lymphocyte function (mice) |
$186,378 |
FY91 |
5 RO1 ES05372-02 |
Mechanisms of neurotoxicity |
$147,803 |
FY91 |
5 RO1 ES05433-02 |
Late consequences of prenatal exposure to methyl mercury (mice) |
$180,228 |
FY91 |
2 S14 GM05231-04 SUB:0002 |
Kentucky State University Research Support Programs |
$26,041 |
FY91 |
5 S06 GM08025-21 SUB 0015 |
Minority biomedical research support program at Southern University SUB TITLE Bioaccumulation in selected tissues of |
$33,191 |
FY91 |
5 S06 GM08169-13 |
MBRS Program at Selma University |
$75,272 |
FY91 |
2 S06 GM08225-07 |
Minority biomedical research support at Lehman College SUB TITLE Target sites and compartmentalization in heavy metal exposed cells |
$46,928 |
FY91 |
5 RO1 GM28211-12 |
Regulation and structure of the mercury operon (E coli) |
$149,449 |
FY91 |
5 R29 GM36722~04 |
Evolution and regulation of mercuric resistance genes (bacteria) |
$111,899 |
FY91 |
5 R29 GM38784-05 |
Mechanistic study of the MeRR metalloregulatory protein |
$107,255 |
FY91 |
5 S06 GM45199-02 |
Biomedical sciences research improvement program (BSRIP) SUB TITLE Amalgam, urine mercury levels, and cognitive functioning. |
$90,621 |
FY91 |
5 RO1 NS25165-03 |
Laser microprobe analysis of neuronal mercury in ALS (human) |
$117,400 |
FY91 |
5 MO1 RR00095-31 SUB:0319 |
General clinical research center |
$33,853 |
FY91 |
5 P51 RR00166-30 SUB:0078 |
Regional primate research center SUB TITLE Selenium effects of methylmercury metabolism |
$48,810 |
FY91 |
5 P51 RR00166-30 |
Regional primate research center |
$48,810 |
FY91 |
5 P51 RR0016-30 |
Regional primate research center SUB TITLE Brain uptake of inorganic mercury (cynos) |
$48,810 |
FY91 |
ZO1 ES49003-02 |
Environmental effects on fertility (Hg Occ expose and repro effects in dental assistants) |
$0 |
FY9l |
Z01RR10001-23 |
Pharmacokinetics (PBPK of Hg) |
$0 |
FY9l |
Attachment 3
1378 Computer Retrieval of Information on Scientific Projects (CRISP)
U. S. National Institutes of Health
Division of Research Grants
Research Documentation Section
Westwood Building, Room 148
5333 Westbard Avenue
Bethesda, Maryland 20892
Basic Information
Provides descriptions and indexing of biomedical research project supported by U.S. Public Health Service grants, cooperative agreements, and career award and research contracts, as well as intramural projects conducted by the National Institutes of Health; the Alcohol, Drug Abuse, and Mental Health Administration; the Centers for Disease Control and Prevention; the Food and Drug Administration; and others. Types of Database: Bibliographic. Language of Database: English. Time span Covered: 1972 to the present. File Size: 625,000 records.
Subject Coverage
Research in biomedical and allied health fields. Input Sources: Applications, progress reports, research contract documents; annual reports, project narratives, and other government documents.
Data Elements
Typical Records Items: Project identification number, title; investigator, address; institution; sponsoring agency; primary terms; project abstract (if furnished)
User Aids
CRISP Thesaurus (annual) - contains more than 10,000 subject headings; available for purchase from the U.S. National Technical Information Service, 5285 Port Royal Rd., Springfield, VA 22161.
Database Availability
Online: BRS Information Technologics. File Label: CRISP. Covers 1986 to the present. Rates/Conditions:
$40 per connect hour (Open Access Plan); discounts available through the Advance Purchase Plan; 15 cents per full record displayed online; 20 cents per full record printed offline. As part of Federal Research in Progress and TOXLINE: each. database is described In a separate entry. Batch Access: Producer offers search services.
Print/lMicroform Products
Publications: Biomedical Index to PHS Supported Research (annual). Intramural Research Index to NIH, NIMH and NIAA Projects (annual).
Contact
James Cain, Chief, Research Documentation Section. Facsimile (301) 496-9975. Electronic Mail: 14C@NIHCU (BITNET).